Navigation Links
Autonomy Powers Award-Winning Website for Leading Swiss Pharmaceutical Company
Date:6/22/2011

CAMBRIDGE, England and SAN FRANCISCO, June 22, 2011 /PRNewswire/ -- Autonomy Corporation plc (LSE: AU. or AU.L), a global leader in infrastructure software for the enterprise, today announced that the website of leading Swiss pharmaceutical company Actelion, powered by Autonomy's flagship Web Content Management (WCM) platform, has twice consecutively been named the winner of the Swiss Pharma Site Monitor performance report. The Swiss Pharma Site Monitor report, which provides a unique combination of insights on key competences, ranging from web diagnostic reporting and usability to online strategy and management, cites Actelion's website, www.actelion.com, as "a clear example that other companies can look up to."

Headquartered in Switzerland, Actelion is a biopharmaceutical company focusing on the discovery, development and commercialization of innovative treatments to serve high, unmet medical needs. Actelion has subsidiaries in 29 countries, covering all major pharmaceutical markets worldwide. The company leverages Autonomy's meaning-based WCM solution to effectively manage and optimize web content segmentation and delivery in order to meet the customer experience needs of its diverse target groups.

Powered by the Intelligent Data Operating Layer (IDOL), Autonomy WCM is the industry's only solution to leverage pattern-based technology to form, in real-time, a conceptual and contextual understanding of all customer interactions from multiple channels, and enable the automatic delivery of optimized online content.  Autonomy TeamSite allows Actelion employees to create and deliver the content on its website from an intuitive, unified interface, while Autonomy LiveSite enables the creation of dynamic, interactive and targeted sites for any purpose, such as a special corporate announcement. By enabling Actelion employees to easily create and dynamically deliver highly-targeted, consistent, and engaging web content, Autonomy's WCM solution was able to seamlessly support a comprehensive creative re-design of the Actelion website in early 2011.

The Swiss Pharma Site Monitor utilizes an objective, state-of-the-art benchmarking system that weighs all criteria relevant for the success of a website, which it divides into the three main areas of 'quality', 'usability', and 'business value'. In its latest 2011 report, the Swiss Pharma Site Monitor evaluated over a hundred websites operated by pharmaceutical companies in Switzerland, and named www.actelion.com 'Overall Winner by Total Score', after having previously awarded the website the same standing in 2010. The report cites Actelion's website as possessing "consistent strength across multiple disciplines," allowing it to "clearly leave the competition trailing in its wake."

"Since the implementation of Autonomy's WCM platform, Actelion's website has been awarded the highest ranking by the Swiss Pharma Site Monitor twice in a row. It has also undergone comprehensive creative redesign," commented Actelion. "Autonomy WCM has had a pivotal role in making this a reality by giving us a powerful, intelligent and easy-to-use online marketing platform for managing our strategic initiatives and significantly reducing time to web."

"As the industry's most integrated and comprehensive solution, Autonomy WCM enjoys a track record of powering over 20,000 websites worldwide, including those of some of the largest global brands," said James Murray, VP Autonomy Promote Solutions EMEA. "The fact that one of these websites, Actelion, has twice been independently recognized for its excellence is a further testament to the concrete benefits of the Autonomy solution."

As a future extension to its longstanding partnership with Autonomy, Actelion plans to adopt more of Autonomy's meaning-based platform for enterprise search and analytics, also powered by IDOL, to penetrate all information silos, derive maximum value from corporate assets, and boost employee productivity, while minimizing the risks endemic to information proliferation.

Please visit www.autonomy.com/wcm to find out more.

About AutonomyAutonomy Corporation plc (LSE: AU. or AU.L), a global leader in infrastructure software for the enterprise, spearheads the Meaning Based Computing movement. IDC recently recognized Autonomy as having the largest market share and fastest growth in the worldwide search and discovery market. Autonomy's technology allows computers to harness the full richness of human information, forming a conceptual and contextual understanding of any piece of electronic data, including unstructured information, such as text, email, web pages, voice, or video. Autonomy's software powers the full spectrum of mission-critical enterprise applications including pan-enterprise search, customer interaction solutions, information governance, end-to-end eDiscovery, records management, archiving, business process management, web content management, web optimization, rich media management and video and audio analysis.

Autonomy's customer base is comprised of more than 25,000 global companies, law firms and federal agencies including: AOL, BAE Systems, BBC, Bloomberg, Boeing, Citigroup, Coca Cola, Daimler AG, Deutsche Bank, DLA Piper, Ericsson, FedEx, Ford, GlaxoSmithKline, Lloyds TSB, NASA, Nestle, the New York Stock Exchange, Reuters, Shell, Tesco, T-Mobile, the U.S. Department of Energy, the U.S. Department of Homeland Security and the U.S. Securities and Exchange Commission. More than 400 companies OEM Autonomy technology, including Symantec, Citrix, HP, Novell, Oracle, Sybase and TIBCO. The company has offices worldwide. Please visit www.autonomy.com to find out more.

Autonomy and the Autonomy logo are registered trademarks or trademarks of Autonomy Corporation plc. All other trademarks are the property of their respective owners. Autonomy Editorial Contacts:Maria Chotreva

David VindelAutonomy (UK)  

The Red Consultancy (UK) +44 207 104 5745

+ 44 207 025 6529maria.chotreva@autonomy.com

david.vindel@redconsultancy.com   Edward Bridges

Louise KehoeFinancial Dynamics (UK)

Ogilvy PR (US)+44 207 831 3113

+1 415 677 2739edward.bridges@fd.com

louise.kehoe@ogilvypr.com  
'/>"/>

SOURCE Autonomy Corporation plc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. LodgeNet Healthcares eSUITE Solution Empowers Patients to Participate in Their Care
2. GNC Empowers Consumers to Age Well With Exclusive New Line Designed to Proactively Influence Health Destiny
3. 3G Wireless Technology Empowers Patients to Take Control of Their Health Through the Dulce Wireless Tijuana Project
4. NanoPowers Raises CHF 5 Million ($4.5 Million) in Series A Financing to Support Development of Breakthrough Urinary Incontinence Device
5. Leading Japanese University Powers Diagnostic Imaging Research With Isilon IQ
6. Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R)
7. Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument
8. The Next Generation in Bilevel Therapy Now Available on ResMeds Award-Winning S9™ Platform
9. Celleration Inc. Announces Award-Winning Clinical Results to Reduce Unfavorable Deep Tissue Injury Outcomes
10. Fenwal Named Exclusive Provider of AccuVeins Award-Winning Vein Illumination Device for Blood and Plasma Centers
11. Award-Winning U.S. Talk Show Host Montel Williams Joins Rex Bionics New International Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb 23, 2017 Research and ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... drug pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer ...
(Date:2/23/2017)... Regulus Therapeutics Inc . (Nasdaq: RGLS), ... innovative medicines targeting microRNAs, today announced it will release ... Thursday, March 2, 2017 after the market closes. ... on March 2, 2017 at 5:00 p.m. Eastern Time ... results and provide a general business update.  A live ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... & Trends - Industry Forecast to 2025" report to their ... The ... around 6.9% over the next decade to reach approximately $47.6 billion ... estimates and forecasts for all the given segments on global as ...
Breaking Medicine Technology:
(Date:2/24/2017)... , ... February 24, 2017 , ... ... into the Senior International Elite division on February 12th. Ms. Esparza qualified ... at the elite qualifier competition held in Las Vegas, Nevada. Frida is one ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an official 2017 partnership with The Jensie Gran Fondo of Marin. For the ... UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide ...
(Date:2/23/2017)... ... February 23, 2017 , ... The 89th Academy Awards will be celebrated this ... Education Policy Center Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek ... winner is the Center for American Progress (CAP), for its report, Lessons From State ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... clinician-based audience, will be participating in Rare Disease Day events, hosted by the ... addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will be ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, ... June: From Not to Hot,” which will begin airing on February 24, 2017. The ... millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier ...
Breaking Medicine News(10 mins):